AILERON Trademark

Trademark Overview

On Thursday, February 15, 2007, a trademark application was filed for AILERON with the United States Patent and Trademark Office. The USPTO has given the AILERON trademark a serial number of 77108337. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 9, 2012. This trademark is owned by Aileron Therapeutics, Inc.. The AILERON trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical compositions, namely, preparations for the treatment of cancer, diabetes, neurodegenerative disorders, cardiovascular disease and disorders, metabolic syndrome, autoimmune disorders, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological disorders, anxiety, depression, neuropsychiatric disorders including both psychotic and non-psychotic conditions, and substance abuse disorders, including both abuse and dependence, disorders of blood cell production, organ transplant rejection, endocrinologic disorders, and bacterial, viral and fungal diseases; diagnostic products, namely, medical diagnostic reagents, diagnostic reagents for clinical or medical laboratory use; biological reagents for medical purpose...
aileron

General Information

Serial Number77108337
Word MarkAILERON
Filing DateThursday, February 15, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 9, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 16, 2008

Trademark Statements

Goods and Servicespharmaceutical compositions, namely, preparations for the treatment of cancer, diabetes, neurodegenerative disorders, cardiovascular disease and disorders, metabolic syndrome, autoimmune disorders, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological disorders, anxiety, depression, neuropsychiatric disorders including both psychotic and non-psychotic conditions, and substance abuse disorders, including both abuse and dependence, disorders of blood cell production, organ transplant rejection, endocrinologic disorders, and bacterial, viral and fungal diseases; diagnostic products, namely, medical diagnostic reagents, diagnostic reagents for clinical or medical laboratory use; biological reagents for medical purposes in the field of molecular biology; and reagents for use in biological processing for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 21, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAileron Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameAileron Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, April 9, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 9, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 6, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 3, 2011EXTENSION 5 GRANTED
Friday, September 2, 2011EXTENSION 5 FILED
Friday, September 2, 2011TEAS EXTENSION RECEIVED
Friday, March 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 10, 2011EXTENSION 4 GRANTED
Friday, March 4, 2011EXTENSION 4 FILED
Friday, March 4, 2011TEAS EXTENSION RECEIVED
Wednesday, January 12, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 12, 2011TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 14, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 13, 2010EXTENSION 3 GRANTED
Friday, September 10, 2010EXTENSION 3 FILED
Friday, September 10, 2010TEAS EXTENSION RECEIVED
Tuesday, April 6, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 5, 2010EXTENSION 2 GRANTED
Wednesday, March 10, 2010EXTENSION 2 FILED
Monday, April 5, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 10, 2010TEAS EXTENSION RECEIVED
Thursday, September 10, 2009EXTENSION 1 GRANTED
Thursday, September 10, 2009EXTENSION 1 FILED
Thursday, September 10, 2009TEAS EXTENSION RECEIVED
Tuesday, March 10, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 16, 2008PUBLISHED FOR OPPOSITION
Wednesday, November 26, 2008NOTICE OF PUBLICATION
Monday, November 10, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 7, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 7, 2008EXAMINER'S AMENDMENT ENTERED
Friday, November 7, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 7, 2008EXAMINERS AMENDMENT E-MAILED
Friday, November 7, 2008EXAMINERS AMENDMENT -WRITTEN
Thursday, July 10, 2008NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, July 10, 2008FINAL REFUSAL E-MAILED
Thursday, July 10, 2008FINAL REFUSAL WRITTEN
Tuesday, June 24, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 24, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 24, 2008ASSIGNED TO LIE
Tuesday, June 24, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 20, 2008APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 20, 2008TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 26, 2007NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, December 26, 2007PRIORITY ACTION E-MAILED
Wednesday, December 26, 2007PRIORITY ACTION WRITTEN
Friday, December 14, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 14, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 6, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 4, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 4, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 6, 2007NON-FINAL ACTION MAILED
Wednesday, June 6, 2007NON-FINAL ACTION WRITTEN
Tuesday, June 5, 2007ASSIGNED TO EXAMINER
Wednesday, February 21, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

aileron disorders diseases reagents medical diagnostic dysfunction abuse psychotic both namely